Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Chemioterapia per carcinoma mammario | da $19,200 | da $1,200 | da $15,000 |
| Chemioterapia Intraperitoneale Ipertermica (HIPEC) | da $23,500 | da $22,500 | da $40,000 |
| Resezione dell'intestino tenue | - | da $12,150 | da $25,000 |
| Radioterapia per il cancro intestinale | - | da $5,800 | da $6,917 |
| Radioterapia per il cancro colorettale | - | da $7,000 | da $12,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Cancro dell'intestino tenue. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Cancro dell'intestino tenue e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Cancro dell'intestino tenue.
Il medico è un esperto di cancro al seno leader in Corea del Sud ed è riconosciuto tra i 100 migliori chirurghi al mondo per il cancro gastrico e al seno. Il medico ha introdotto la chirurgia conservativa del seno in Corea del Sud nel 1986 e ha inventato un intervento chirurgico unico per il cancro allo stomaco che minimizza il rischio di malattia da reflusso gastroesofageo. Attualmente, il medico dirige il Centro per il Cancro delle Donne presso il Centro Medico dell'Università Ewha Womans e ha precedentemente ricoperto il ruolo di Presidente dell'Ospedale Universitario Konkuk e Direttore dell'Ospedale del Centro per il Cancro della Corea. Il medico è anche un ricercatore attivo nella diagnosi e gestione del cancro al seno.<\/p>
Il medico è il Direttore del Centro Oncologico Yonsei presso il Sistema Sanitario dell'Università Yonsei a Seul, Corea del Sud. Specializzato nel trattamento del cancro gastrico avanzato, il medico ha una vasta esperienza in chirurgia, oncologia e gastroenterologia.<\/p>
Il medico ha ricoperto posizioni prestigiose come Presidente dell'Associazione Coreana del Cancro Gastrico e dell'Associazione Internazionale del Cancro Gastrico, e Presidente del Consiglio dell'Associazione Coreana del Cancro e della Società Chirurgica Coreana.<\/p>
Riconosciuto come un chirurgo eccezionale nella chirurgia del cancro gastrico, il medico ha ricevuto numerosi riconoscimenti, tra cui il Premio Accademico per il Cancro e il Premio Accademico Yuhan.<\/p>
Il dottore è un esperto in chirurgia oncoplastica e cancro al seno, con una vasta esperienza in istituzioni prestigiose. Il dottore possiede una laurea in medicina (M.D.) dal College of Medicine della Seoul National University e un master in chirurgia (M.S.) dalla stessa istituzione. Inoltre, il dottore ha conseguito una laurea in scienze biologiche (B.S.) presso il Korea Advanced Institute of Science and Technology (KAIST) e un dottorato di ricerca (Ph.D.) in chirurgia presso la Graduate School della Seoul National University.<\/p>
Samsung Medical Center, Seoul National University Hospital (SNUH), and Asan Medical Center are the premier hospitals for small intestine cancer treatment in South Korea. These JCI-accredited tertiary centers provide multidisciplinary oncology teams. They utilize advanced PET/CT imaging and robotic surgical systems for complex tumor resections.
Bookimed Expert Insight: While patients often seek famous names, our data shows institutional capacity is the real quality signal. Asan Medical Center manages over 182,000 oncology patients yearly. This massive volume ensures surgeons see rare small intestine cases frequently. This level of specialization is often unavailable in smaller regional clinics.
Patient Consensus: Patients emphasize finding a hospital that conducts pathology reviews in-house to ensure accurate staging. Many note that choosing centers with dedicated international departments significantly simplifies scheduling and translation during complex treatments.
South Korea offers multi-stage small intestine cancer treatment including surgical resection, advanced chemotherapy, and robotic surgery. Specialized centers utilize Da Vinci systems and laparoscopic techniques for localized tumors. Systemic options include HIPEC, immunotherapy (Keytruda), and targeted therapies for specific subtypes like neuroendocrine tumors or adenocarcinoma.
Bookimed Expert Insight: While many choose Asan Medical Center for its massive 2,700-bed capacity, Seoul National University Hospital often sees the highest-ranking officials due to its historical reputation. If you require robotic surgery, Korea University Anam Hospital is a strategic choice because they pioneered several robotic surgical firsts in Asia.
Patient Consensus: Patients note that verifying the tumor subtype early is vital because treatment plans for adenocarcinoma differ significantly from GIST or neuroendocrine tumors. They also recommend seeking care at centers with dedicated gastrointestinal oncology teams for the best coordination.
South Korea reports global-leading 5-year survival rates for gastrointestinal cancers, exceeding 75% for bowel and 76% for stomach malignancies. These outcomes often surpass US and European averages. High-volume tertiary centers in Seoul utilize PET-CT and Da Vinci robotic systems within JCI-accredited facilities to improve results.
Bookimed Expert Insight: Patient volume is the strongest predictor of success for rare small intestine cancers in Korea. Asan Medical Center treats over 14,000 patients daily, ensuring surgeons handle more rare GI cases in a month than many Western specialists see in a year. This concentrated experience directly leads to more accurate staging and fewer surgical complications.
Patient Consensus: Patients note that major Korean hospitals act quickly with imaging and surgery. They emphasize ensuring your case is reviewed by a multidisciplinary tumor board for the most accurate pathology results.
Korean oncology centers offer advanced robotic and minimally invasive surgery for small intestine cancer. Facilities like Samsung Medical Center use da Vinci systems for precise tumor resection. Surgeons frequently employ laparoscopic or robotic-assisted techniques to treat localized malignancies with smaller incisions and faster recovery.
Bookimed Expert Insight: While most elite centers focus on volume, Korea University Anam Hospital stands out for specialized robotic precision. It developed the first robotic oral thyroid surgery and leads in complex reconstructions. This technical mastery often translates to better handling of difficult small intestine tumor locations. You should prioritize centers with documented robotic experience in varied abdominal oncology rather than just surgery volume.
Patient Consensus: Patients note that robotic options are routine in Seoul but emphasize that surgeons decide on the technique based on tumor size and depth. They often advise bringing full pathology reports to help surgeons determine if a minimally invasive approach is realistic.
International patients can join small intestine cancer clinical trials in South Korea. The country serves as a global oncology hub with high-volume multinational studies. Eligibility depends on trial protocols, hospital policies, and sponsorship. Major facilities like Samsung Medical Center and Asan Medical Center host these advanced research programs.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and handles over 45,000 surgeries. This massive volume drives their involvement in phase II and III trials. Patients should target these high-capacity centers. They often have dedicated research coordinators for international participants. This infrastructure simplifies enrollment and provides access to global therapeutics.
Patient Consensus: Patients note that logistics like frequent scans and local addresses are common hurdles. Reliable translation services are critical for understanding consent forms and maintaining trial eligibility.
Ask about the surgical resectability of the tumor and the specific involvement of nearby lymph nodes. Confirm the pathology results, including tumor grade and margins. In Korea, verify if a multidisciplinary tumor board at a JCI-accredited facility will review your treatment plan.
Bookimed Expert Insight: South Korean oncology centers like Seoul National University Hospital and Samsung Medical Center maintain some of the highest cancer treatment statistics globally. A major differentiator is their high-volume capacity, with some clinics treating over 10,000 patients daily. When discussing your plan, ask specifically about the internal coordinator system. These digitalized hospitals use advanced tracking to ensure seamless communication between surgical and oncology departments.
Patient Consensus: Patients emphasize the need to clarify how the surgery will impact daily eating habits and long-term vitamin absorption. Many also suggest asking about symptoms that require urgent care, like bowel obstructions or sudden dehydration.